Scheinberg DA - Search Results

1

Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies.

Caron PC, Co MS, Bull MK, Avdalovic NM, Queen C, Scheinberg DA. Caron PC, et al. Among authors: scheinberg da. Cancer Res. 1992 Dec 15;52(24):6761-7. Cancer Res. 1992. PMID: 1458463

2

Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma.

Bajorin DF, Chapman PB, Wong GY, Cody BV, Cordon-Cardo C, Dantes L, Templeton MA, Scheinberg D, Oettgen HF, Houghton AN. Bajorin DF, et al. Melanoma Res. 1992 Dec;2(5-6):355-62. doi: 10.1097/00008390-199212000-00009. Melanoma Res. 1992. PMID: 1292783

3

Engineered humanized dimeric forms of IgG are more effective antibodies.

Caron PC, Laird W, Co MS, Avdalovic NM, Queen C, Scheinberg DA. Caron PC, et al. Among authors: scheinberg da. J Exp Med. 1992 Oct 1;176(4):1191-5. doi: 10.1084/jem.176.4.1191. J Exp Med. 1992. PMID: 1402660 Free PMC article.

4

Current applications of monoclonal antibodies for the therapy of hematopoietic cancers.

Scheinberg DA. Scheinberg DA. Curr Opin Immunol. 1991 Oct;3(5):679-84. doi: 10.1016/0952-7915(91)90096-j. Curr Opin Immunol. 1991. PMID: 1661602 Review.

5

Inhibition of cell proliferation with an HLA-A-specific monoclonal antibody.

Scheinberg DA, Bull MK, Yang SY, Class KA, Minniti JG. Scheinberg DA, et al. Tissue Antigens. 1991 Nov;38(5):213-23. doi: 10.1111/j.1399-0039.1991.tb01900.x. Tissue Antigens. 1991. PMID: 1723543

6

A monoclonal antibody for terminal beta-galactose. Use in analysis of glycosphingolipids.

Kalisiak A, Oosterwijk E, Minniti JG, Old LJ, Scheinberg DA. Kalisiak A, et al. Among authors: scheinberg da. Glycoconj J. 1991 Feb;8(1):55-62. doi: 10.1007/BF00731643. Glycoconj J. 1991. PMID: 1726670

7

Chimeric and humanized antibodies with specificity for the CD33 antigen.

Co MS, Avdalovic NM, Caron PC, Avdalovic MV, Scheinberg DA, Queen C. Co MS, et al. Among authors: scheinberg da. J Immunol. 1992 Feb 15;148(4):1149-54. J Immunol. 1992. PMID: 1737932

8

Monoclonal antibodies against Gal alpha 1-4Gal beta 1-4Glc (Pk, CD77) produced with a synthetic glycoconjugate as immunogen: reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors.

Oosterwijk E, Kalisiak A, Wakka JC, Scheinberg DA, Old LJ. Oosterwijk E, et al. Among authors: scheinberg da. Int J Cancer. 1991 Jul 30;48(6):848-54. doi: 10.1002/ijc.2910480610. Int J Cancer. 1991. PMID: 1860732

9

Radioimmunotherapy in experimental animal models: principles derived from models.

Scheinberg DA, Strand M. Scheinberg DA, et al. Cancer Res. 1990 Feb 1;50(3 Suppl):962s-963s. Cancer Res. 1990. PMID: 2297749

10

Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.

Tanimoto M, Scheinberg DA, Cordon-Cardo C, Huie D, Clarkson BD, Old LJ. Tanimoto M, et al. Among authors: scheinberg da. Leukemia. 1989 May;3(5):339-48. Leukemia. 1989. PMID: 2716349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters